Slated to start at Knight Campus in October 2021
Gabriella Lindberg completed her master’s degree in biotechnology and tissue engineering at Chalmers University of Technology in Sweden. Passionate about developing new generation biomaterials, she worked at a spin-off medical device company for four years before she moved to New Zealand to pursue a PhD in biomedical engineering at the University of Otago. She later completed a two years post-doc and was promoted to Research Fellow in 2019 in the Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group.
Her research is focused on the design of cell-instructive hydrogels, bioinks, and bioresins that mimic the native architectural organization and biological niche of musculoskeletal tissues, capable of adapting to the constantly changing micro-environment as new tissue is forming. Through controlled delivery of cells, growth factors and oxygen, she is progressing the clinical relevance of bioinks, establishing structure-to-function relationships, and further advancing 3D-models to highlight patient-to-patient variability and model disease progression and implant integration. Her research is part of larger collaborative projects involving both national and international collaborators in the likes of New Zealand, Germany, Netherlands and Australia.
She holds a New Zealand Health Research Council Emerging Researcher Grant and has also won several other awards such as the International Society of Biofabrication (ISBF) young investigator award in 2019, the Consortium for Medical Device Technologies (CMDT) and the Medical Technologies Centre of Research Excellence (MedTech CoRE) award also in 2019, and University of Otago’s integrity award in 2017.